Literature DB >> 527257

Circulating immune complexes in carcinoma of uterine cervix.

P Seth, N Balachandran, A N Malaviya, R Kumar.   

Abstract

Circulating immune complexes were determined in the sera of forty-eight patients wital status by inhibition of rheumatoid factor (RF) maediated agglutination of IgG coated latex particles. The inhibitory activity was present in 63% of the sera from cervical cancer patients but only 13% of sera from control women contained this activity. Similarly, anticomplementary activity suggestive of the presence of immune complexes was present in 71% of sera from cancer patients and 13% of sera from control women. The incidence as well as the levels of immune complexes (IC) were higher in sera of patients with advanced stages of cancer as compared to those with Stage I cervical cancer. In addition, 95% of sera from cervical cancer patients had cryoblobulins, whereas only 20.8% sera from matched controls were positive for cryoprecipitates. All the cryoglobulins contained IgG type of immunoglobulin except one which had IgA immunoglobulins also. The complexes have not been characterized with regard to the nature of the antigen(s) present.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 527257      PMCID: PMC1537848     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Circulating immune complexes in patients following clinically curative resection of colorectal cancer.

Authors:  G Steele; S Sonis; P Stelos; R Rittgers; N Zamcheck; D Finn; J Maltz; R Mayer; J Lokich; R E Wilson
Journal:  Surgery       Date:  1978-06       Impact factor: 3.982

2.  The nature of immune complexes in human cancer sera.

Authors:  A N Theofilopoulos; B S Andrews; M M Urist; D L Morton; F J Dixon
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

3.  Circulating immune complexes in patients with breast cancer.

Authors:  K Hoffken; I D Meredith; R A Robins; R W Baldwin; C J Davies; R W Blamey
Journal:  Br Med J       Date:  1977-07-23

4.  Analysis of serum blocking factors against leukocyte dependent antibody in melanoma patients.

Authors:  E Murray; S Ruygrok; G W Milton; P Hersey
Journal:  Int J Cancer       Date:  1978-05-15       Impact factor: 7.396

5.  Circulating immune complexes in patients with malignant lymphomas and solid tumors.

Authors:  H E Heier; N Carpentier; G Lange; P H Lambert; T Godal
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

6.  Detection of antigen-antibody complexes in cancer patients.

Authors:  R D Rossen
Journal:  Antibiot Chemother (1971)       Date:  1978

7.  Circulating immune complexes in infants fed on cow's milk.

Authors:  M Delire; C L Cambiaso; P L Masson
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

8.  The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.

Authors:  R D Rossen; M A Reisberg; E M Hersh; J U Gutterman
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

9.  Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.

Authors:  H Teshima; H Wanebo; C Pinsky; N K Day
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

10.  Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.

Authors:  N A Carpentier; G T Lange; D M Fiere; G J Fournie; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

View more
  2 in total

1.  Circulating immune complex and NK-cell activity in progressive breast cancer.

Authors:  R Seth; P Seth
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

2.  Prognostic significance of circulating immune complexes in cancer patients.

Authors:  T K Dass; M Aziz; A Rattan
Journal:  Jpn J Cancer Res       Date:  1991-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.